Adicet Bio, Inc. (ACET) Revenue Growth
Adicet Bio, Inc. (ACET) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2019-12-31 | N/A |
| 2020-12-31 | 1699.30% |
| 2021-12-31 | -45.65% |
| 2022-12-31 | -92.76% |
| 2023-12-31 | 1.42% |
| 2024-12-31 | 1.82% |
| 2025-12-31 | N/A |
How ACET compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| IONS | Ionis Pharmaceuticals Inc. | 33.83% |
| NTLA | Intellia Therapeutics Inc. | 16.92% |
| VERU | Veru Inc. | 3.62% |
| BNTC | Benitec Biopharma Inc. | 2.74% |
| EYPT | EyePoint Pharmaceuticals Inc. | -27.50% |
These are five companies in the same sector as ACET with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Adicet Bio, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("ACET", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ACET | $9.26 | +0.00% | 0.06M |
| 3 | ||||
| 4 | ||||
| 5 |